Doctor insights on:
Renova Cancer Agent
Targeted cancer drug: Pertuzumab is a drug that targets cancer cells which carry a certain protein on their surface called her2. It has been approved for treatment of metastatic breast cancer that is her2 overexpressing. You can think of her2 like a light switch that makes cancer cells grow. Pertuzumab blocks the switch from being turned on from the outside. Herceptin is a similar drug. ...Read moreSee 1 more doctor answer
What to do if I use fluorouracil cream(cancer drug) to treat a rash..will I get cancer because of that?
No: Efudex cream is a cutaneous method of applying 5 FU ( a chemotherapeutic agent) to cutaneous basal cell and some cutaneous squamous cell Ca's ..It is applied daily x 10 followed by an application of A&D ointment to the same area that has become inflamed. In many cases the skin tumor will completely regress. Sometimes a repeat treatment needed. Should not be used for rashes. Does not cause Ca. ...Read more
Extensive testing: After going through pre-clinical testing in cell culture lines and animal models, a cancer drug is tested in humans. A phase i trial looks for safety information regarding the maximum tolerated dose of a drug. A phase ii trial looks for initial efficacy possibilities in a particular cancer population. A phase iii trial compares the new treatment against the current standard option. ...Read more
Multidisciplinary: Developing a cancer drug is an involved process that need contributions of chemists, biochemists, molecular biologists, doctors, pharmacologists, and more. Nanotechnology has not played a major role, yet. ...Read more
Many: There are a few drugs that use this idea such as abraxane. There are mulle possibilities. Currently an chemotherapy is attached to a carrier molecule and attached to an antibody for breast cancer. Delivery might be less important than targeting weakness in cancer cells more specifically. ...Read more
Approx how many years will it take for a experimental cancer drug(ima901) beginning from phase-3 to clinically available in market for patients use?
Cannot predict.: Ima901 is an immune therapy (cancer vaccine) for renal cell carcinoma of the kidney. It is currently under investigation in multi center phase 3 trials in europe and the U.S. Our center is not part of the trial, but information at clinicaltrials.Gov shows that phase 3 is currently accruing patients. They estimate data in 2014. It takes a mean of 8 years from the start of phase i trials to market. ...Read moreSee 1 more doctor answer
- Talk to a doctor live online for free
- Is tricalcium phosphate a cancer causing agent?
- Agent orange and thyroid cancer
- Zoladex anti prostate cancer agent
- Ask a doctor a question free online
- Agent orange and colon cancer
- Agent orange and bladder cancer
- Agent orange lung cancer
- Cancer causing agents in food
- Talk to a dermatologist online